Cruiser Capital Advisors, LLC Neuronetics, Inc. Transaction History
Cruiser Capital Advisors, LLC
- $41.7 Million
- Q2 2025
A detailed history of Cruiser Capital Advisors, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Cruiser Capital Advisors, LLC holds 50,000 shares of STIM stock, worth $147,500. This represents 0.42% of its overall portfolio holdings.
Number of Shares
50,000
Previous 50,000
-0.0%
Holding current value
$147,500
Previous $184,000
5.43%
% of portfolio
0.42%
Previous 0.49%
Shares
1 transactions
Others Institutions Holding STIM
# of Institutions
95Shares Held
18.6MCall Options Held
49.6KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA2.74MShares$8.09 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$5.13 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.51MShares$4.45 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$3.24 Million1.17% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$2.95 Million0.14% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $79.7M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...